Basic Information
Basic information for LINC00276-202-14aa
Peptide Name LINC00276-202-14aa
Genome Position chr2:14230552-14230593[-]
Species Human
Peptide Sequence MLFLSNYQLHFSQN
Peptide Length 14
Unique No (HCG18-246-14aa-3,HCG18-249-14aa-2,HCG18-250-14aa-3,HCG18-251-14aa-2,HCG18-252-14aa-2,HCG18-254-14aa-3,HCG18-255-14aa-3,HCG18-256-14aa-3,HCG18-257-14aa-3,HCG18-258-14aa-3,HCG18-259-14aa-3,HCG18-260-14aa-3,HCG18-261-14aa-2,HCG18-262-14aa-3,HCG18-263-14aa-2,HCG18-265-14aa-3,HCG18-266-14aa-3,HCG18-267-14aa-2,HCG18-268-14aa-3)
Grand Average of Hydropathicity -0.0857
Relative Molecular Mass 1976.17
Experimental Evidences no
lncRNA ID/Name ENSG00000230448;LINC00276
Transcript ID/Name ENST00000418420;LINC00276-202
Transcript Length 3503
Coding Ability 0.3794
DNA Sequence Corresponding to Peptide ATGCTATTTCTATCAAACTACCAATTACATTTTTCACAGAAT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :